Michael Bookman - Net Worth and Insider Trading

Michael Bookman Net Worth

The estimated net worth of Michael Bookman is at least $3,339 dollars as of 2024-05-26. Michael Bookman is the GENERAL COUNSEL AND SECRETARY of Immuneering Corp and owns about 2,402 shares of Immuneering Corp (IMRX) stock worth over $3,339. Details can be seen in Michael Bookman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Bookman has not made any transactions after 2022-05-17 and currently still holds the listed stock(s).

Transaction Summary of Michael Bookman

Michael Bookman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Bookman owns 3 companies in total, including Frequency Therapeutics Inc (FREQ) , Immuneering Corp (IMRX) , and Korro Bio Inc (KRRO) .

Click here to see the complete history of Michael Bookman’s form 4 insider trades.

Insider Ownership Summary of Michael Bookman

Ticker	Comapny	Transaction Date	Type of Owner
FREQ	Frequency Therapeutics Inc	2021-01-19	General Counsel and Secretary
IMRX	Immuneering Corp	2022-05-17	General Counsel and Secretary
KRRO	Korro Bio Inc	2021-01-19	General Counsel and Secretary

Michael Bookman Latest Holdings Summary

Michael Bookman currently owns a total of 1 stock. Michael Bookman owns 2,402 shares of Immuneering Corp (IMRX) as of May 17, 2022, with a value of $3,339.

Latest Holdings of Michael Bookman

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
IMRX	Immuneering Corp	2022-05-17	2,402	1.39	3,339

Holding Weightings of Michael Bookman

Michael Bookman Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Bookman has made a total of 2 transactions in Immuneering Corp (IMRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Immuneering Corp is the acquisition of 1,000 shares on May 17, 2022, which cost Michael Bookman around $4,880.

Insider Trading History of Michael Bookman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Bookman Trading Performance

GuruFocus tracks the stock performance after each of Michael Bookman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Bookman is 47.67%. GuruFocus also compares Michael Bookman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Bookman within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michael Bookman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michael Bookman

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	19.3
Relative Return to S&P 500(%)	23.09

Michael Bookman Ownership Network

Ownership Network List of Michael Bookman

No Data

Ownership Network Relation of Michael Bookman

Michael Bookman Owned Company Details

What does Frequency Therapeutics Inc do?

Who are the key executives at Frequency Therapeutics Inc?

Michael Bookman is the General Counsel and Secretary of Frequency Therapeutics Inc. Other key executives at Frequency Therapeutics Inc include director & President and CEO David L. Lucchino , VP Finance & Operations Richard J. Mitrano , and Chief Scientific Officer Christopher R. Loose .

Frequency Therapeutics Inc (FREQ) Insider Trades Summary

Over the past 18 months, Michael Bookman made no insider transaction in Frequency Therapeutics Inc (FREQ). Other recent insider transactions involving Frequency Therapeutics Inc (FREQ) include a net sale of 97,675 shares made by David L. Lucchino , a net sale of 8,202 shares made by Richard J. Mitrano , and a net sale of 26,723 shares made by Christopher R. Loose .

In summary, during the past 3 months, insiders sold 0 shares of Frequency Therapeutics Inc (FREQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 132,600 shares of Frequency Therapeutics Inc (FREQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,600 shares.

Frequency Therapeutics Inc (FREQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Frequency Therapeutics Inc Insider Transactions

No Available Data

What does Immuneering Corp do?

Who are the key executives at Immuneering Corp?

Michael Bookman is the General Counsel and Secretary of Immuneering Corp. Other key executives at Immuneering Corp include 10 percent owner Cormorant Asset Management, Lp , Vice President & Finance Mallory Morales , and Chief Business Officer Harold Eugene Brakewood .

Immuneering Corp (IMRX) Insider Trades Summary

Over the past 18 months, Michael Bookman made no insider transaction in Immuneering Corp (IMRX). Other recent insider transactions involving Immuneering Corp (IMRX) include a net sale of 1,309,091 shares made by Cormorant Asset Management, Lp , a net purchase of 100,000 shares made by Peter Feinberg , and a net purchase of 57,965 shares made by Ann E Berman .

In summary, during the past 3 months, insiders sold 1,309,091 shares of Immuneering Corp (IMRX) in total and bought 197,083 shares, with a net sale of 1,112,008 shares. During the past 18 months, 1,309,091 shares of Immuneering Corp (IMRX) were sold and 197,083 shares were bought by its insiders, resulting in a net sale of 1,112,008 shares.

Immuneering Corp (IMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immuneering Corp Insider Transactions

No Available Data

What does Korro Bio Inc do?

Who are the key executives at Korro Bio Inc?

Michael Bookman is the General Counsel and Secretary of Korro Bio Inc. Other key executives at Korro Bio Inc include 10 percent owner Scott D Sandell , 10 percent owner New Enterprise Associates 17, L.p. , and 10 percent owner Rick Yang .

Korro Bio Inc (KRRO) Insider Trades Summary

Over the past 18 months, Michael Bookman made no insider transaction in Korro Bio Inc (KRRO). Other recent insider transactions involving Korro Bio Inc (KRRO) include a net sale of 2,124 shares made by David L. Lucchino , a net purchase of 17,857 shares made by Paul Edward Walker , and a net purchase of 17,857 shares made by Rick Yang .

In summary, during the past 3 months, insiders sold 0 shares of Korro Bio Inc (KRRO) in total and bought 178,570 shares, with a net purchase of 178,570 shares. During the past 18 months, 2,124 shares of Korro Bio Inc (KRRO) were sold and 178,570 shares were bought by its insiders, resulting in a net purchase of 176,446 shares.

Korro Bio Inc (KRRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Korro Bio Inc Insider Transactions

No Available Data

Michael Bookman Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Bookman. You might contact Michael Bookman via mailing address: C/o Frequency Therapeutics, Inc., 10 Presidential Way, 2nd Floor, Woburn Ma 01801.

Discussions on Michael Bookman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.